Deepinder Goyal-backed Temple acquires London longevity firm Longevous

Wearable startup Temple has acquired London-based Longevous ahead of its launch, adding clinical and scientific expertise. Longevous co-founders Dr Robert Mohr and Dr Avi Roy will join Temple as chief medical officer and head of science.

— Source publishedThu, 27 Aug, 2026, 16:27 IST·First seen Thu, 27 Aug, 2026, 16:33 IST·Source YourStory

What happened

Deepinder Goyal-backed wearable startup Temple acquired London-based longevity firm Longevous to strengthen clinical and scientific capabilities before launch.

Key facts

  • Founded in 2024
  • Temple was tested for two months
  • Dr Robert Mohr has nearly two decades of clinical experience

Why this matters

Temple’s acquisition illustrates how wearable entrants can accelerate credibility and product-development capabilities by acquiring specialist clinical talent alongside a target’s expertise.

What to watch

  • Whether Temple positions itself as a wellness tracker, clinical decision-support tool, or regulated medical device.
  • Launch of proprietary biomarker, biological-age, or disease-risk scores.
  • Clinical study announcements, peer-reviewed publications, or medical advisory-board additions.
  • Partnerships with diagnostics labs, clinics, insurers, employers, or pharmaceutical companies.
  • Pricing strategy, subscription attachment, and evidence of willingness to pay versus established devices such as Oura, WHOOP, Apple Watch, and Garmin.
  • Regulatory filings or changes in marketing language that indicate medical-claim ambition.
  • Announce product launch timing, hardware specifications, and initial market geography.
  • Recruit additional clinical, regulatory, data-science, and biosignal-validation talent.
  • Establish pilot programs with longevity clinics, preventive-health providers, corporate wellness platforms, or research institutions.
  • Publish validation data or methodology for metrics such as recovery, cardiovascular health, sleep, metabolic health, or biological-age proxies.
  • Raise a seed or Series A round framed around preventive health and clinically actionable wearables.

Also reported by